14 Dec 2021

'Brain fog' during menopause is real – it can disrupt women's work and spark dementia fears

For nearly two-thirds of women, menopause comes with an undesirable change in memory.

Despite great progress in understanding the medical aspects of menopause – a natural part of life that occurs when a woman has not had a menstrual period for 12 months – we are only beginning to recognise the experience and impact of cognitive changes during menopause.

See The Conversation article (December 14) by Caroline Gurvich, Chen Zu and Shalini Arunogiri.

Central Clinical School's 2021 wrap by Professor Terry O'Brien

Hear about the highs and lows of 2021 for Central Clinical School from our Head, Professor Terry O'Brien. Another big year, the second of the pandemic.

See the video or flick through the slide deck, embedded on our CCS intranet page:

Bioengineered skin breakthrough to revolutionise burns treatment

Dr Cheng Lo in theatre with a burns patient
Researchers from The Alfred and the Faculty of Medicine, Nursing and Health Sciences are developing bio-engineered skin that will undergo a large trial in third-degree burn patients, starting in 2023.

Victorian Adult Burns Centre director Adjunct Associate Professor Heather Cleland and head of the skin bioengineering laboratory Adjunct Associate Professor Shiva Akbarzadeh spoke to the Herald Sun about the cutting-edge technique. A/Prof Cleland also spoke on ABC Radio's Mornings program.

Monash Trauma group researchers explore the influence of the gut microbiome and repetitive traumatic brain injury on adolescent bone development

by Ms Kerrui Wong, Ms Marissa Sgro and Dr Loretta Piccenna

Adolescence is a sensitive period for bone development. Changes during this critical period may lead to significant long-term complications, for example osteopenia and osteoporosis later in life. New research from the Monash Trauma group in the Department of Neuroscience at the Central Clinical School indicates that weakening of the gut microbiome with antibiotic treatment and repetitive mild traumatic brain injury each individually stunted bone growth and volume, and did so in a sex-dependent manner during adolescence. 

Scans of the femur bone density and volume with different treatments using microcomputed tomography

Vanguard Grant for novel method of measuring oxidative stress in diabetic vascular disease

Dr Tomasz Block explains the utilisation of an immune
cell biomarker to measure oxidative stress in patients
with diabetic vascular disease. See video

Congratulations to Dr Tomasz Block, who has been awarded a Vanguard Grant from the Heart Foundation, for $75,000.

Dr Block is an Advanced Trainee in Endocrinology at Monash Health commencing in 2022 and a current Adjunct Research Associate, in the Diabetes and Kidney Disease (Jandeleit-Dahm) research group in the Department of Diabetes at the Central Clinical School. He will utilise this opportunity to expand on novel clinical research based on exciting preliminary results from a pilot study presented at both national and international congresses.

12 Dec 2021

Dr Warwick Nesbitt is a MedTech Actuator Menzies Fellow 2022

Dr Warwick Nesbitt and colleague Dr Crispin Szydzik.
Image: Medtech
Two Australian researchers have been announced as MedTech Actuator Menzies Fellows 2022.

Congratulations to Dr Warwick Nesbitt, Australian Centre for Blood Diseases (ACBD) and Dr Gregory Stewart who are set to transform their research impact. 

The MedTech Actuator Menzies Fellowship is supported by the Menzies Foundation as part of their Entrepreneurship in Science mission in partnership with the MedTech Actuator.

Welcome to Associate Professor Rebecca Disler, respiratory researcher

Professor Terry O'Brien, CCS Head of School, writes:

It gives me great pleasure and excitement to announce the recruitment of Dr Rebecca Disler to the academic Monash University appointment as Associate Professor and ARC Discovery Early Career Researcher Award (DECRA) Fellow in the Respiratory Research@Alfred section of the Department of Immunology and Pathology in the Central Clinical School. 

Welcome to our new recruit, Dr Joseph Kong!

Dr Joseph Kong
Welcome to Dr Joseph Kong

Professor Terry O'Brien, Head of Central Clinical School, writes:

It is with great pleasure that I can announce the recruitment of Dr Joe Kong, MBChB, MS, PhD, FRACS to an 0.5 FTE academic appointment as a Senior Research Fellow (Level C) in the Department of Surgery, Central Clinical School, Monash University. 

Welcome (back) to Melanie Le Page

Melanie Le Page, new ARA FlowCore manager

Welcome back to Mélanie Le Page, who has returned to Central Clinical School! She writes:

"After leaving Central Clinical School almost 10 years ago, following appointments at WEHI, oNKo-innate and Hudson Institute, I have returned as manager of ARA FlowCore and am excited to share my extensive experience in flow cytometry and operational laboratory management with the precinct. 

Related Posts Plugin for WordPress, Blogger...